Biotricity Launches Biocare Cardiac Application for Samsung’s Galaxy Watch4 Series
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare…
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public offering of 5,000,000 shares of com
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021
REDWOOD CITY, Calif., Jun 15, 2021 (ACCESSWIRE) — Biotricity, Inc.